KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Dividends Paid - Common (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Dividends Paid - Common for 17 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • Quarterly Dividends Paid - Common rose 7.52% to $1.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 billion through Dec 2025, up 7.3% year-over-year, with the annual reading at $4.1 billion for FY2025, 7.3% up from the prior year.
  • Dividends Paid - Common hit $1.0 billion in Q4 2025 for Abbott Laboratories, roughly flat from $1.0 billion in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $1.0 billion in Q3 2025 to a low of $798.0 million in Q4 2021.
  • Historically, Dividends Paid - Common has averaged $901.0 million across 5 years, with a median of $889.0 million in 2023.
  • Biggest five-year swings in Dividends Paid - Common: rose 25.39% in 2021 and later increased 3.11% in 2022.
  • Year by year, Dividends Paid - Common stood at $798.0 million in 2021, then rose by 3.13% to $823.0 million in 2022, then rose by 7.9% to $888.0 million in 2023, then increased by 7.88% to $958.0 million in 2024, then grew by 7.52% to $1.0 billion in 2025.
  • Business Quant data shows Dividends Paid - Common for ABT at $1.0 billion in Q4 2025, $1.0 billion in Q3 2025, and $1.0 billion in Q2 2025.